Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence
Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence
MADISON, Wis., Sept. 3, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that President and Chief Executive Officer Suzanne Winter will be taking a temporary medical leave of absence to receive care for a treatable form of cancer, effective immediately. Accuray Senior Vice President and Chief Commercial Officer Sandeep Chalke will serve as the interim CEO during Ms. Winter's absence. To ensure that Mr. Chalke and the organization have the necessary support, the company has formed an Executive Committee of the Board of Directors, consisting of Joseph Whitters, Chairman of the Accuray Board, and Anne Le Grand, Chair of the Science and Technology Committee, that will advise Mr. Chalke in his interim capacity.
2024年9月3日，威斯康星州麥迪遜-(新華社)/精確射線公司(NASDAQ: ARAY)宣佈，總裁兼首席執行官蘇珊娜·溫特將因一種可治療的癌症而暫時離職，即刻生效。在溫特女士暫時離職期間，精確射線公司高級副總裁兼首席商務官桑迪普·查爾克將充任臨時CEO。爲確保查爾克先生和公司得到必要的支持，該公司成立了董事會的常務委員會，由精確射線董事會主席約瑟夫·韋特斯和科學技術委員會主席安妮·勒·格蘭德組成，他們將在查爾克先生擔任臨時CEO期間提供諮詢意見。
"As the head of an incredible company whose mission is to conquer cancer, I remain grateful for how far the industry has come in overcoming this disease, including the development of advanced diagnostic tools that can detect it in early stages. I go into my treatment program extremely knowledgeable and able to advocate for the care I need," said Suzanne Winter, President and CEO of Accuray.
"作爲一家使命是征服癌症的不可思議公司的負責人，我對行業在克服這種疾病方面取得的進展感到非常感激，包括開發能夠在早期階段檢測出它的先進診斷工具。我進入我的治療計劃時非常有知識，並能夠爲自己所需的護理辯護，"精確射線公司總裁兼首席執行官蘇珊娜·溫特說。
"Suzanne will be in the thoughts of the Board and the global Accuray organization while she takes time to prioritize her health," said Joseph Whitters, Chairman of the Board at Accuray. "In the interim, the Board and I are extremely confident in Sandeep and the strong leadership team that Suzanne has built. I am certain that they are well positioned to continue delivering on the organization's vision and strategic priorities while concurrently running day-to-day operations."
"蘇珊娜在重視自己的健康期間，董事會和全球精確射線組織將關注她的健康問題，"精確射線董事會主席約瑟夫·韋特斯表示。"在此期間，董事會和我對桑迪普和蘇珊娜建立的強大領導團隊充滿信心。我相信他們在同時進行日常運營的同時，也能夠繼續實現組織的願景和戰略重點。"
Mr. Chalke joined Accuray in May 2022 bringing more than 30 years of medical device expertise in commercialization, business development and operations. In his role at Accuray, he has responsibility for the global commercial function, including the organization's sales, service and operations teams.
查爾克先生於2022年5月加入精確射線公司，擁有30多年的醫療器械市場化、業務拓展和運營方面的專業知識。在精確射線公司擔任職務期間，他負責全球商務職能，包括銷售、服務和運營團隊。
About Accuray
Accuray Incorporated is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit or follow us on Facebook, LinkedIn, X, and YouTube.
關於Accuray公司
精確射線公司致力於拓展放射治療的巨大潛力，以改善盡可能多的生活。我們發明了獨特的，改變市場的解決方案，旨在爲即使是最複雜的病例提供放射治療--同時使常見可治療病例更加容易，以滿足患者的全部需求。我們致力於放射治療在腫瘤學、神經放射外科和更多領域的持續創新，與臨床醫生和管理人員合作，賦予權力幫助患者更快地回到他們的生活中。精確射線公司總部位於威斯康星州麥迪遜，擁有全球設施。了解更多信息，請訪問 網址或關注我們的 Facebook、LinkedIn、X和YouTube頁面。
Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
[email protected]
投資者聯繫方式
阿曼·帕特爾，特許金融分析師
投資者關係，ICR-Westwicke
+1（443）450-4191
[email protected]
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
[email protected]
媒體聯繫人
Beth Kaplan
公共關係主管，精確射線
+1（408）789-4426
[email protected]
SOURCE Accuray Incorporated
來源：精確射線公司
譯文內容由第三人軟體翻譯。